Portfolio company
Isabl
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops whole genome and transcriptome sequencing software for oncology centres and pharmaceutical companies to improve cancer diagnosis and treatment planning.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GenomOncology
This company develops software platforms to analyse and interpret genomic data for molecular pathology labs, clinical oncologists and research institutions.
Cambridge Cancer Genomics
This company develops precision oncology software for clinicians to monitor treatment response and detect cancer relapse using genomic data and blood samples.
Fabric Genomics
This company provides a clinical software platform for genomic data interpretation and reporting to diagnostic laboratories and hospital systems.
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
Oncompass
Oncompass develops oncology software that identifies genetic mutations to help clinicians select personalised cancer treatment options for patients.
Astron Health
This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.
MyPL
This company provides a clinical data visualisation platform for oncology healthcare professionals to support therapeutic decision-making and patient care management.
Genomill Health
Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.
